Skip to main content

FDA Approves Foundation Medicine's FoundationOne CDx Diagnostic Test for Solid Tumors

By: via Benzinga
Foundation Medicine, Inc. (NASDAQ: FMI) announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne CDx™, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.